Skip to Main Content

Paper Details

Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Pediatr Blood Cancer
8
2021
NF1, NF1-OPGs, OPG, children, everolimus, neurofibromatosis type 1-associated optic pathway gliomas
Author NameAffiliation
Sanjay P PrabhuBoston Children's Hospital
Roger J PackerCenter for Neuroscience and Behavioral Medicine, Children's National Hospital
Roger J PackerCenter for Neuroscience and Behavioral Medicine, Children's National Hospital
Stewart GoldmanAnn and Robert Lurie Children's Hospital
Jeffrey C AllenNYU Langone Medical Center
David H GutmannWashington University School of Medicine
Michael J FisherChildren's Hospital of Philadelphia
Mark W Kieran
Mark W Kieran
  • 1 - 9

Datasets

Release 1.2